Interview: Tzu-Ling (Karen) Tseng – CEO, Bio Preventive Medicine Corporation, Taiwan

Untitled (2)Dr. Tzu-Ling (Karen) Tseng, CEO of Bio Preventive Medicine Corporation in Taiwan, discusses the innovative technology of its patented biomarkers, the success of DNlite and company’s strategy to grow through partnerships with global pharmaceutical companies. What was your vision when you founded Bio Preventive Medicine Corporation (BPM) in 2014? Can you introduce BPM to our readers?
"Currently, our focus areas are the complications of diabetes, including kidney and heart complication, as well as renal injury."
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In

Related Interviews

Latest Report